Cargando…
The optogenetic promise for oncology: Episode I
As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and ang...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905200/ https://www.ncbi.nlm.nih.gov/pubmed/27308360 http://dx.doi.org/10.4161/23723548.2014.964045 |
_version_ | 1782437227818647552 |
---|---|
author | Ingles-Prieto, Alvaro Reichhart, Eva Schelch, Karin Janovjak, Harald Grusch, Michael |
author_facet | Ingles-Prieto, Alvaro Reichhart, Eva Schelch, Karin Janovjak, Harald Grusch, Michael |
author_sort | Ingles-Prieto, Alvaro |
collection | PubMed |
description | As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and angiogenic sprouting—cell behaviors central to cancer progression. |
format | Online Article Text |
id | pubmed-4905200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-49052002016-06-15 The optogenetic promise for oncology: Episode I Ingles-Prieto, Alvaro Reichhart, Eva Schelch, Karin Janovjak, Harald Grusch, Michael Mol Cell Oncol Author's View As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and angiogenic sprouting—cell behaviors central to cancer progression. Taylor & Francis 2014-10-29 /pmc/articles/PMC4905200/ /pubmed/27308360 http://dx.doi.org/10.4161/23723548.2014.964045 Text en © 2014 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. |
spellingShingle | Author's View Ingles-Prieto, Alvaro Reichhart, Eva Schelch, Karin Janovjak, Harald Grusch, Michael The optogenetic promise for oncology: Episode I |
title | The optogenetic promise for oncology: Episode I |
title_full | The optogenetic promise for oncology: Episode I |
title_fullStr | The optogenetic promise for oncology: Episode I |
title_full_unstemmed | The optogenetic promise for oncology: Episode I |
title_short | The optogenetic promise for oncology: Episode I |
title_sort | optogenetic promise for oncology: episode i |
topic | Author's View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905200/ https://www.ncbi.nlm.nih.gov/pubmed/27308360 http://dx.doi.org/10.4161/23723548.2014.964045 |
work_keys_str_mv | AT inglesprietoalvaro theoptogeneticpromiseforoncologyepisodei AT reichharteva theoptogeneticpromiseforoncologyepisodei AT schelchkarin theoptogeneticpromiseforoncologyepisodei AT janovjakharald theoptogeneticpromiseforoncologyepisodei AT gruschmichael theoptogeneticpromiseforoncologyepisodei AT inglesprietoalvaro optogeneticpromiseforoncologyepisodei AT reichharteva optogeneticpromiseforoncologyepisodei AT schelchkarin optogeneticpromiseforoncologyepisodei AT janovjakharald optogeneticpromiseforoncologyepisodei AT gruschmichael optogeneticpromiseforoncologyepisodei |